2018
DOI: 10.1002/mabi.201870009
|View full text |Cite
|
Sign up to set email alerts
|

Macromol. Biosci. 4/2018

Abstract: Front Cover: Engineering optical nano‐vesicles derived from red blood cells with theranostic functionalities to fluorescently image and lyse blood clots. This is reported by Raviraj Vankayala, Samantha R. Corber, Jenny T. Mac, Masaru P. Rao, Mohammad Shafie, and Bahman Anvari, article number https://doi.org/10.1002/mabi.201700379.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(10 citation statements)
references
References 0 publications
0
10
0
Order By: Relevance
“…[210,211] Besides, it was proved that the system of EM-NVs-ICG was also suitable for imaging of ischemic stroke. [212] Liu. et al have synthesized a core-shell zinc gallogermanate nanostructuresmesoporous SiO 2 and further enveloped by EM-NVs.…”
Section: Biological Sensor and Diagnosticsmentioning
confidence: 99%
See 1 more Smart Citation
“…[210,211] Besides, it was proved that the system of EM-NVs-ICG was also suitable for imaging of ischemic stroke. [212] Liu. et al have synthesized a core-shell zinc gallogermanate nanostructuresmesoporous SiO 2 and further enveloped by EM-NVs.…”
Section: Biological Sensor and Diagnosticsmentioning
confidence: 99%
“…[ 210,211 ] Besides, it was proved that the system of EM‐NVs‐ICG was also suitable for imaging of ischemic stroke. [ 212 ] Liu. et al.…”
Section: Biomedical Applications Of Erythrocyte‐inspired Materialsmentioning
confidence: 99%
“…Vankayala designed a multifunctional nanoplatform with imaging detection and therapeutic thrombosist (Figure 3F, tPAconjugated NETs). [46] An NIR imaging agent ICG was loaded into nanoscale erythrocyte membranes and then combined with tissue fibrinogen activator tPA for the construction of the probe. tPA, is the only existing Food and Drug Administrationapproved pharmacologic treatment for ischemic stroke, and is a naturally occurring enzyme that catalyzes the conversion of plasminogen to plasmin when bound to fibrin in blood clots, resulting in dissolution of clots.…”
Section: Fibrin-targeting and Fibrinogen-targetingmentioning
confidence: 99%
“…Vankayala designed a multifunctional nanoplatform with imaging detection and therapeutic thrombosist (Figure 3F, tPA‐conjugated NETs) [46] . An NIR imaging agent ICG was loaded into nanoscale erythrocyte membranes and then combined with tissue fibrinogen activator tPA for the construction of the probe.…”
Section: Thrombus Probe For Fluorescence Imagingmentioning
confidence: 99%
“…In another example, RBC membranes were loaded with indocyanine green, a near-infrared imaging agent, as well as tPA for dissolving clots through the conversion of plasminogen to plasmin. 191 Here, the cell membrane acted to prolong the circulation of the formulation through immunomodulatory markers on the surface, while the tPA targeted clots via favorable fibrin binding. In vitro blood clot localization studies demonstrated significantly higher accumulation of the tPA-conjugated formulation when compared to unconjugated formulations, suggesting future utility of the platform for ischemic stroke applications.…”
Section: Diagnosticsmentioning
confidence: 99%